School of Clinical Oncology Final (1).pn
Holding Slide Spine Mets.jpg

Speaker: Dr Daniel Tan

Chairperson: Dr Rajendra Tiruchelvarayan

 

Synopsis: Up to 30 percent of patients with metastatic disease will develop deposits to the spine. Management of spinal metastases is complex as it involves considerations relating to the cancer, the patient’s neurological function as well as symptom control (pain and stability). Traditionally patients are referred for palliative radiotherapy if and when they become symptomatic, or in other instances as an urgent referral to the spine surgeon due to cord compression. 

 

This talk will provide an update on the management of spine metastases in the modern era where an all or none approach is no longer the default and patients have access to various options to ensure durable symptom control and functional preservation.